Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative × Ipilimumab × 30 days × Clear all

Sponsor

Conditions

Melanoma 14 Carcinoma, Renal Cell 12 Carcinoma, Non-Small-Cell Lung 6 Neoplasm Metastasis 5 Squamous Cell Carcinoma of Head and Neck 4 Skin Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Hepatocellular 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Small Cell Lung Carcinoma 3 Kidney Neoplasms 3 Glioblastoma 3 Carcinoma, Merkel Cell 3 Brain Neoplasms 3 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Prostatic Neoplasms 2 Penile Neoplasms 2 Neuroendocrine Tumors 2 Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Gliosarcoma 2 Glioma 2 Colorectal Neoplasms 2 Carcinoma, Endometrioid 2 Carcinoma, Basal Cell 2 Carcinoma 2

Interventions

Specimen Handling 3 Biopsy 3 Azacitidine 2 venetoclax 1 veliparib 1 pevonedistat 1 peginterferon alfa-2b 1 onvansertib 1 axatilimab 1 Topotecan 1 High-Energy Shock Waves 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡